Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Omni Shoreham Hotel

Dec 05, 2016 1:00 PM - Dec 06, 2016 5:00 PM

2500 Calvert Street NW, , Washington, DC 20008 , USA

Advancing the Science of Study Endpoints

Examine global strategies for selecting study endpoints and the impact of endpoints during the analysis of clinical evidence for various types of drug approval processes.

Session 6: Meaningful Score Changes to Establish Endpoint Definitions

Session Chair(s)

David H. Schubert

David H. Schubert

DH Schubert Regulatory Solutions LLC, United States

Working from the starting point that the concepts we are measuring are meaningful, and that the instruments for measuring these have been developed according to industry standards and have demonstrated measurement properties. It is next necessary to determine what is a meaningful score change in order to establish endpoint specification prospectively. This interactive session will integrate audience status and opinion feedback via their Smartphones.

Speaker(s)

Dragos  Roman, MD

Performance Based Measures

Dragos Roman, MD

FDA, United States

Associate Dir., Division of Gastroenterology & Inborn Errors Products, OND, CDER

Alan  Shields, PhD

Patient Reported Outcomes Status Update: Challenges, Observations, and (Some) Solutions from the Field

Alan Shields, PhD

Adelphi Values, United States

Vice President Patient Centered Outcomes

Karon  Cook, PhD

A Novel Method for Estimating Responder Thresholds

Karon Cook, PhD

Northwestern University, United States

Research Professor

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.